Formulation: A crystalline solid
Pricing updated 2018-05-25. Prices are subject to change without notice.
3,4-MDEA-d5 (hydrochloride) (Item No. 15821) is intended for use as an internal standard for the quantification of 3,4-MDEA (Item Nos. 14085 | ISO60196) by GC- or LC-MS. 3,4-MDEA is categorized as an amphetamine. It has similar psychotropic action to MDMA and shares the common name of "ecstasy".1 Postmortem findings in human deaths associated with 3,4-MDEA as well as 3,4-MDMA indicate striking brain and myocardial damage as well as liver necrosis.2 3,4-MDEA-d5 is regulated as a Schedule I compound in the United States. This product is intended for research and forensic applications.
Warning - this product is not for human or veterinary use.
View our Base Peak Identification Tool
View our Flipbook Identification Tool
View the Cayman Structure Database for chemical structure definitions for many Cayman products
View the Cayman Spectral Library (CSL) for ChemStation-searchable GC-MS spectra of many of Cayman's emerging forensic drug standards
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data pack, and GC-MS data.
Freudenmann, R.W., and Spitzer, M. The neuropsychopharmacology and toxicology of 3,4-
2. Milroy, C.M., Clark, J.C., and Forrest, A.R.W. Pathology of deaths associated with "ecstasy" and "eve" misuse. J. Clin. Pathol. 49(2), 149-153 (1996).
It appears that there is a heterogenous mixture of deuterated species in your deuterated standards; is this normal?
Yes, this is typical of our deuterated products. Our deuterated products contain less than 1 % d0. However, the labeled compounds are not 100% of the deuterated form listed on our product insert. For example, upon analysis of 2-arachidonoyl glycerol-d8 it is expected to see masses associated with the d7, d6, d5 etc.